Recommended Laboratory Tests for PCOS Diagnosis
For patients suspected of having Polycystic Ovary Syndrome (PCOS), a comprehensive laboratory evaluation should include first-line tests of total testosterone (using LC-MS/MS), calculated free testosterone or Free Androgen Index (FAI), TSH, and prolactin, with second-line tests including 17-hydroxyprogesterone, androstenedione, DHEAS, and metabolic assessments. 1
First-Line Laboratory Tests
Androgen Assessment:
Exclusion of Other Disorders:
Second-Line Laboratory Tests
When initial results are abnormal or clinical suspicion remains high:
Additional Androgen Tests:
Adrenal Function Tests:
- Overnight dexamethasone suppression test or 24-hour urinary free cortisol (to rule out Cushing's syndrome) 1
Metabolic Assessment
Glucose Metabolism:
Lipid Profile:
Imaging Studies
- Transvaginal Ultrasound:
Special Considerations
- For Adolescents:
Diagnostic Algorithm
- Step 1: Assess clinical features (irregular menses, hirsutism, acne)
- Step 2: Order first-line tests (testosterone, free testosterone/FAI, TSH, prolactin)
- Step 3: If first-line tests are abnormal or clinical suspicion remains high, order second-line tests
- Step 4: Perform metabolic assessment (glucose tolerance test, lipid profile)
- Step 5: Obtain transvaginal ultrasound (if appropriate)
- Step 6: Diagnose PCOS if at least two of three criteria are present:
- Chronic anovulation
- Hyperandrogenism (clinical or biochemical)
- Polycystic ovaries on ultrasound
Common Pitfalls to Avoid
- Relying solely on ultrasound findings for diagnosis 1
- Using standard immunoassays for testosterone measurement instead of LC-MS/MS 2
- Failing to exclude other disorders that can mimic PCOS 1
- Not assessing metabolic parameters, which are crucial for comprehensive management 1, 3
- Overlooking the importance of SHBG measurement, which affects free testosterone levels and reflects metabolic disturbances 2
Remember that PCOS diagnosis requires at least two of three criteria (chronic anovulation, hyperandrogenism, polycystic ovaries) with exclusion of other relevant disorders 1. The laboratory evaluation should be comprehensive to establish the diagnosis and assess associated metabolic risks.